$AKBA
Akebia Therapeutics, Inc.

2017 Q2 Form 10-Q Financial Statement

#000156459017016542 Filed on August 08, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $28.52M $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.900M $5.300M
YoY Change 30.19% 43.24%
% of Gross Profit
Research & Development $43.80M $30.90M
YoY Change 41.75% 330.24%
% of Gross Profit
Depreciation & Amortization $100.0K $46.00K
YoY Change 117.39% 43.75%
% of Gross Profit
Operating Expenses $50.66M $36.19M
YoY Change 39.98% 232.34%
Operating Profit -$22.14M -$36.19M
YoY Change -38.83% 232.34%
Interest Expense $608.0K $300.0K
YoY Change 102.67% 200.0%
% of Operating Profit
Other Income/Expense, Net $618.0K $409.0K
YoY Change 51.1% 104.5%
Pretax Income -$21.50M -$35.80M
YoY Change -39.94% 234.58%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$21.52M -$35.78M
YoY Change -39.86% 234.73%
Net Earnings / Revenue -75.45%
Basic Earnings Per Share -$0.53
Diluted Earnings Per Share -$0.53 -$947.1K
COMMON SHARES
Basic Shares Outstanding 40.82M
Diluted Shares Outstanding 40.82M

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $316.6M $161.1M
YoY Change 96.54% 41.25%
Cash & Equivalents $125.4M $46.18M
Short-Term Investments $191.2M $114.9M
Other Short-Term Assets $11.20M $3.900M
YoY Change 187.18% 85.71%
Inventory
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $332.4M $192.5M
YoY Change 72.66% 24.24%
LONG-TERM ASSETS
Property, Plant & Equipment $2.900M $1.832M
YoY Change 58.3% 360.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.500M $1.281M
YoY Change 17.1% 320.0%
Total Long-Term Assets $4.400M $3.113M
YoY Change 41.34% 342.82%
TOTAL ASSETS
Total Short-Term Assets $332.4M $192.5M
Total Long-Term Assets $4.400M $3.113M
Total Assets $336.8M $195.6M
YoY Change 72.16% 25.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.20M $5.143M
YoY Change 98.33% 113.23%
Accrued Expenses $28.90M $15.79M
YoY Change 83.04% 352.28%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $181.6M $20.93M
YoY Change 767.57% 254.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $98.20M $9.000K
YoY Change 1091011.11% -10.0%
Total Long-Term Liabilities $98.20M $9.000K
YoY Change 1091011.11% -10.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $181.6M $20.93M
Total Long-Term Liabilities $98.20M $9.000K
Total Liabilities $279.8M $62.35M
YoY Change 348.78% 954.41%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $356.2M
YoY Change 30.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $57.00M $133.3M
YoY Change
Total Liabilities & Shareholders Equity $336.8M $195.6M
YoY Change 72.19% 25.65%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$21.52M -$35.78M
YoY Change -39.86% 234.73%
Depreciation, Depletion And Amortization $100.0K $46.00K
YoY Change 117.39% 43.75%
Cash From Operating Activities $24.37M -$26.95M
YoY Change -190.43% 122.54%
INVESTING ACTIVITIES
Capital Expenditures -$150.0K -$1.250M
YoY Change -88.0% 4066.67%
Acquisitions
YoY Change
Other Investing Activities -$31.54M $31.04M
YoY Change -201.61% -830.35%
Cash From Investing Activities -$31.69M $29.79M
YoY Change -206.38% -796.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 45.46M -90.00K
YoY Change -50611.11% -100.14%
NET CHANGE
Cash From Operating Activities 24.37M -26.95M
Cash From Investing Activities -31.69M 29.79M
Cash From Financing Activities 45.46M -90.00K
Net Change In Cash 38.14M 2.750M
YoY Change 1286.91% -94.31%
FREE CASH FLOW
Cash From Operating Activities $24.37M -$26.95M
Capital Expenditures -$150.0K -$1.250M
Free Cash Flow $24.52M -$25.70M
YoY Change -195.41% 112.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
182000
CY2017Q2 us-gaap License And Services Revenue
LicenseAndServicesRevenue
28520000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
253000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-389000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3413000
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-33823000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
79000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8173000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2830000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1547000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6362000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
40588000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
40000000
akba Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
380000
akba Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
1337000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
14836000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9521000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
575000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1358000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
54118000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
64874000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
177536000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
118684000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-123993000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-55168000
akba Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
46912000
akba Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
60869000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
125000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
105000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
178000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
120000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
3000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
6000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
47212000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
61088000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-61945000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3601000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49778000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46177000
akba Deferred Follow On Offering Issuance Costs
DeferredFollowOnOfferingIssuanceCosts
137000
akba Deferred Follow On Offering Issuance Costs
DeferredFollowOnOfferingIssuanceCosts
131000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
40000
CY2016Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
187335000
CY2017Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
195825000
CY2017Q2 akba Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
22576000
CY2016Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
260383000
CY2016Q4 akba Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
260343000
CY2017Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
191182000
CY2017Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
4643000
akba Operating Plan Sufficiently Funded By Cash Resources Period
OperatingPlanSufficientlyFundedByCashResourcesPeriod
P12M
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3629000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
695000
CY2017Q2 us-gaap Depreciation
Depreciation
100000
akba Number Of Accounting Units
NumberOfAccountingUnits
3
CY2016 akba Cost Share Payment Received For License Agreement
CostSharePaymentReceivedForLicenseAgreement
33800000
CY2017Q1 akba Estimate Subsequent Cost Share Payment Receivable
EstimateSubsequentCostSharePaymentReceivable
153600000
akba Allocated Arrangement Consideration Under License Agreement
AllocatedArrangementConsiderationUnderLicenseAgreement
312400000
akba Milestone Payment Received
MilestonePaymentReceived
236700000
CY2017Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
196078000
CY2017Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
253000
CY2017Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
125390000
CY2017Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
321468000
CY2016Q4 akba Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
23643000
CY2017Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1750000
CY2016Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2995000
CY2017Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
761000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
539000
CY2017Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
681000
CY2016Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
513000
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2437000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1975000
CY2017Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
6783823
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5268127
CY2017Q2 akba Allocated Share Based Compensation Expense Reversal
AllocatedShareBasedCompensationExpenseReversal
2505000
CY2017Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
646000
CY2016Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
596000
CY2016Q2 akba Allocated Share Based Compensation Expense Reversal
AllocatedShareBasedCompensationExpenseReversal
1222000
akba Allocated Share Based Compensation Expense Reversal
AllocatedShareBasedCompensationExpenseReversal
7933000
akba Allocated Share Based Compensation Expense Reversal
AllocatedShareBasedCompensationExpenseReversal
2473000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
45362
us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
242000
akba Operating Lease Payments Commencement Date
OperatingLeasePaymentsCommencementDate
2017-01-01
CY2017Q2 us-gaap Incentive From Lessor
IncentiveFromLessor
2169920
CY2017Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
70526
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1773000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3545000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3545000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3545000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
3510000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
14666000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
30584000
CY2017Q2 akba Operating Leases Future Minimum Sublease Rental Income Remainder Of Fiscal Year
OperatingLeasesFutureMinimumSubleaseRentalIncomeRemainderOfFiscalYear
129000
CY2017Q2 akba Operating Leases Future Minimum Sublease Rental Income Due In Two Years
OperatingLeasesFutureMinimumSubleaseRentalIncomeDueInTwoYears
257000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
386000
CY2017Q2 akba Operating Leases Net Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesNetFutureMinimumPaymentsRemainderOfFiscalYear
1644000
CY2017Q2 akba Operating Leases Net Future Minimum Payments Due In Two Years
OperatingLeasesNetFutureMinimumPaymentsDueInTwoYears
3288000
CY2017Q2 akba Operating Leases Net Future Minimum Payments Due In Three Years
OperatingLeasesNetFutureMinimumPaymentsDueInThreeYears
3545000
CY2017Q2 akba Operating Leases Net Future Minimum Payments Due In Four Years
OperatingLeasesNetFutureMinimumPaymentsDueInFourYears
3545000
CY2017Q2 akba Operating Leases Net Future Minimum Payments Due In Five Years
OperatingLeasesNetFutureMinimumPaymentsDueInFiveYears
3510000
CY2017Q2 akba Operating Leases Net Future Minimum Payments Due Thereafter
OperatingLeasesNetFutureMinimumPaymentsDueThereafter
14666000
CY2017Q2 akba Operating Leases Net Future Minimum Payments Due
OperatingLeasesNetFutureMinimumPaymentsDue
30198000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
4000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
5000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
9000
CY2017Q2 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
9000
CY2017Q2 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
1648000
CY2017Q2 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
3293000
CY2017Q2 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
3545000
CY2017Q2 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
3545000
CY2017Q2 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
3510000
CY2017Q2 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
14666000
CY2017Q2 us-gaap Contractual Obligation
ContractualObligation
30207000
CY2017Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
800000
CY2016Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
700000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1600000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1000000
us-gaap Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross
ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
26500000
CY2016 us-gaap Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross
ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
24900000
CY2017Q2 akba Purchase Committed Program Remaining Contract Costs
PurchaseCommittedProgramRemainingContractCosts
334700000
CY2017Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
39000
CY2016Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
29000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
200000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
100000
akba Defined Contribution Plan Employees Age To Be Eligible Under Plan
DefinedContributionPlanEmployeesAgeToBeEligibleUnderPlan
P21Y
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5394994
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3310361
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5394994
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3310361

Files In Submission

Name View Source Status
0001564590-17-016542-index-headers.html Edgar Link pending
0001564590-17-016542-index.html Edgar Link pending
0001564590-17-016542.txt Edgar Link pending
0001564590-17-016542-xbrl.zip Edgar Link pending
akba-10q_20170630.htm Edgar Link pending
akba-20170630.xml Edgar Link completed
akba-20170630.xsd Edgar Link pending
akba-20170630_cal.xml Edgar Link unprocessable
akba-20170630_def.xml Edgar Link unprocessable
akba-20170630_lab.xml Edgar Link unprocessable
akba-20170630_pre.xml Edgar Link unprocessable
akba-ex101_318.htm Edgar Link pending
akba-ex102_319.htm Edgar Link pending
akba-ex311_11.htm Edgar Link pending
akba-ex312_7.htm Edgar Link pending
akba-ex321_9.htm Edgar Link pending
akba-ex41_317.htm Edgar Link pending
akba-ex991_427.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g201708081939111372180.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending